Bổ sung sắt qua chế độ ăn uống làm gia tăng viêm đại tràng do DSS và sự phát triển ung thư đại trực tràng liên quan ở chuột

Fiocchi C: Inflammatory bowel discase: Etiology and pathogenesis. Gastroenterology 115:182–205, 1998 Collins RH Jr, Feldman M, Fordtran JS: Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis. A critical review. N Engl J Med 316:1654–1658, 1987 Ekbom A, Helmick C, Zack M, Adami H-O: Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 323:1228–1233, 1990 Prior P, Gyde SN, Macartney JC, Thompson H, Waterhouse JAH, Allan RN: Cancer morbidity in ulcerative colitis. Gut 23:490–497, 1982 Meeting Report: Molecular mechanism for inflammationpromoted pathogenesis of cancer-the sixteenth international symposium of the Sapporo cancer seminar. Cancer Res 57:3620–3623, 1997 Barrison IG, Roberts PD, Kane SP: Oral or parenteral iron treatment in chronic ulcerative colitis? Br Med J (Clin Res Ed) 282:514, 1981 Sheth S, Brittenham GM: Genetic disorders affecting proteins of iron metabolism: Clinical implications. Annu Rev Med 51:443–464, 2000 Blake D, Bacon PA: The importance of iron in rheumatoid arthritis. Lancet 1:623, 1982 Reifen R, Matas Z, Zeidel L, Berkovitch Z, Bujanover Y: Iron supplementation may aggravate inflammatory status of colitis in a rat model. Dig Dis Sci 45:394–397, 2000 Meneghini, R: Iron homeostasis, oxidative stress, and DNA damage. Free Radic Biol Med 23:783–792, 1997 Babbs CF: Oxygen radicals in ulcerative colitis. Free Radic Biol Med 13:169–181, 1992 Stevens RG, Graubard BL, Micozzi MS, Neriishi K, Blumberg BS: Moderate elevation of body iron level and increased risk of cancer occurrence and death. Int J Cancer 56:364–369, 1994 Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R: A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98:694–702, 1990 Mahler M, Bristol IJ, Leiter EH, Workman AE, Birkenmeier EH, Elson CO, Sundberg JP: Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis. Am J Physiol 274:G544–G551, 1998 Cooper HS, Murthy S, Kido K, Yoshitake H, Flanigan A: Dysplasia and cancer in the dextran sulfate sodium mouse colitis model. Relevance to colitis-associated neoplasia in the human: a study of histopathology, ?-catenin, and p53 expression and the role of inflammation. Carcinogenesis 21:757–768, 2000 Tamaru T, Kobayashi H, Kishimoto S, Kajiyama G, Shimamoto, F, Brown WR: Histochemical study of colonic cancer in experimental colitis of rats. Dig Dis Sci 38:529–537, 1993 Yamada M, Ohkusa T, Okayasu I: Occurrence of dysplasia and adenocarcinoma after experimental chronic ulcerative colitis in hamsters induced by dextran sulphate sodium. Gut 33:1521–1527, 1992 Riddell RH, Goldman H, Ransohoff DF, Appelman HD, Fenoglio CM, Haggitt RC, Ahren C, Correa P, Hamilton SR, Morson BC, Sommers SC, Yardley JH: Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applications. Hum Pathol 14:931–968, 1983 Goldstein SR, Yang G-Y, Chen X, Curtis SK, Yang CS: Studies of iron deposits, inducible nitric oxide synthase and nitrotyrosine in a rat model for esophageal adenocarcinoma. Carcinogenesis 19:1445–1449, 1998 Yang G-Y, Wang ZY, Kim S, Liao J, Seril DN, Chen XX, Smith TJ, Yang CS: Characterization of early pulmonary hyperproliferation and tumor progression and their inhibition by black tea in a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanoneinduced lung tumorigenesis model with A/J mice. Cancer Res 57:889–1894, 1997 Babbs CF: Hypothesis paper: Free radicals and the etiology of colon cancer. Free Radic Biol Med 8:191–200, 1990 Konijn A: Iron metabolism in inflammation. Bailliere's Clin Haematol 7:829–849, 1994 Morris CJ, Earl JR, Trenam CW, Blake DR: Reactive oxygen species and iron-a dangerous partnership in inflammation. Int J Biochem Cell Biol 27:109–122, 1995 Herbert V, Shaw S, Jayatilleke E, Stopler-Kasdan, T: Most free-radical injury is iron-related: it is promoted by iron, hemin, holoferritin and vitamin C, and inhibited by desferroxamine and apoferritin. Stem Cells 12:289–303, 1994 Wink DA, Vodovotz Y, Laval J, Laval F, Dewhirst MW, Mitchell JB: The multifaceted roles of nitric oxide in cancer. Carcinogenesis 19:711–721, 1998 Reynolds PD, Middleton SJ, Hansford GM, Hunter JO: Nitric oxide in ulcerative colitis. Lancet 345:448–449, 1995 Jacob RA, Burri BJ: Oxidative damage and defense. Am J Clin Nutr 63:985S–990S, 1996 Peskin AV: Interaction of reactive oxygen species with DNA. A review. Biochemistry 62:1341–1347, 1997 Poulsen HE, Prieme H, Loft S: Role of oxidative DNA damage in cancer initiation and promotion. Eur J Cancer Prev 7:9–16, 1998 Schmidt C, Baumeister B, Kipnowski J, Schiermeyer-Dunkhase B, Vetter H: Alteration of prostaglandin E2 and leukotriene B4 synthesis in chronic inflammatory bowel disease. Hepato-Gastroenterol 43:1508–1512, 1996 Reddy BS, Rao CV, Seibert K: Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res 56:4566–4569, 1996 Ablin J, Shalev O, Okon E, Karmeli F, Rachmilewitz D: Deferiprone, an oral iron chelator, ameliorates experimental colitis and gastric ulceration in rats. Inflamm Bowel Dis 5:253–261, 1999 Heimann TM, Oh AC, Martinelli G, Szporn A, Luppescu N, Lembo CA, Kurtz RJ, Fasy TM, Greenstein AJ: Colorectal carcinoma associated with ulcerative colitis: A study of prognostic indicators. Am J Surg 164:3–17, 1992 Sugita A, Greenstein AJ, Ribeiro MB, Sachar DB, Bodian C, Nannan Panday AK, Szporn A, Pozner J, Heimann T, Palmer M, Aufses AH Jr: Survival with colorectal cancer in ulcerative colitis. A study of 102 cases. Ann Surg 218:189–195, 1993 Goldman H: Significance and detection of dysplasia in chronic colitis. Cancer 78:2307–2312, 1996